Current Affairs :- April 2014
Sun Pharmaceutical Industries Ltd to buy generic drugmaker Ranbaxy Laboratories Ltd for $3.2 billion.
"Sun Pharmaceutical Industries Ltd and Ranbaxy Laboratories Ltd today announced that they have entered into definitive agreements pursuant to which Sun Pharma will acquire 100 per cent of Ranbaxy in an all-stock transaction," the two companies said in a statement.
Ranbaxy shareholders will receive 0.8 share of Sun Pharma for each share of Ranbaxy.
Sun Pharmaceutical Industries Ltd to buy generic drugmaker Ranbaxy Laboratories Ltd for $3.2 billion.
"Sun Pharmaceutical Industries Ltd and Ranbaxy Laboratories Ltd today announced that they have entered into definitive agreements pursuant to which Sun Pharma will acquire 100 per cent of Ranbaxy in an all-stock transaction," the two companies said in a statement.
Ranbaxy shareholders will receive 0.8 share of Sun Pharma for each share of Ranbaxy.
No comments:
Post a Comment